Run. - Anonymous employee U.S. Pharmacopeia Employee Review

1.0
Mar 24, 2026
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

Benefits. Otherwise, none that I can think of.

Cons

Too many... All about optics. Transactional and superficial behavior running amok. Job description not accurate. Many hostile, cold, unfriendly people. A lot of these 5 star reviews are obviously HR-planted with use of AI to write them. The USP rating is realistically lower than what you see now... Scary.

avatar
U.S. Pharmacopeia Response
3mo
We’re sorry to hear that your experience at USP led to this perception. We take feedback seriously, including critical perspectives shared on Glassdoor. To be clear, USP does not discourage employees from using Glassdoor, nor do we plant or script reviews. Glassdoor is one of several ways current and former employees choose to share their views, and individual experiences can vary widely across teams, roles, and time periods. For employees within the organization, we also provide multiple internal channels to share feedback or raise concerns directly, including managers, HR Business Partners, Employee Relations, Compliance & Ethics, and our confidential Speak Up line. These avenues exist to ensure concerns can be heard, explored, and addressed appropriately. We regret that this was not a positive chapter for you and wish you well moving forward.

Explore other reviews about U.S. Pharmacopeia

5.0
Nov 11, 2025
Recommend
CEO approval
Business Outlook

Pros

Benefits, people, making an impact, and nonprofit atmosphere

Cons

The base pay is not as competitive as other companies.

1.0
Mar 15, 2026
Recommend
CEO approval
Business Outlook

Pros

There are talented people here, and some teams genuinely try to do good work. The mission sounds compelling on paper.

Cons

Where to start. The DEI program became so overzealous that it stopped being about inclusion and started being about optics and box-checking. Decisions — including hiring, promotions, and project assignments — visibly prioritized optics over merit and competence. Morale among high performers eroded fast. Layoffs were handled poorly and repeatedly. Leadership would announce "we're in a great position" and then cut 10-15% of staff months later. This cycle happened more than once. No accountability, no transparency, just a new all-hands with fresh talking points. Turnover was relentless. Good people left constantly, and leadership either didn't notice or didn't care. Institutional knowledge walked out the door while management patted itself on the back. The infighting between business units was exhausting. Competing priorities, duplicated efforts, and zero alignment from the top. Cross-functional work felt like trench warfare.

7
avatar
U.S. Pharmacopeia Response
3mo
We’re disappointed to hear that your experience at USP led to these conclusions, especially given your long tenure with the organization. We want to address a few points directly. First, assertions of repeated large-scale layoffs are not accurate. While USP has periodically made focused organizational adjustments, we have not conducted ongoing or cyclical reductions at the scale described. When role changes do occur, they are tied to business priorities and communicated with care, not as a contradiction to our overall organizational health. With respect to DEI, USP is proud of a merit-based culture that values expertise, performance, and integrity. Our inclusion efforts are intended to ensure that all qualified individuals, regardless of background or perspective, have equitable access to opportunities and are treated with respect. Hiring, advancement, and project assignments are based on role requirements, skills, and experience, not “optics.” Encouraging diverse viewpoints strengthens scientific rigor and decision-making and is not at odds with high performance. We regret that this was not your experience and appreciate your sharing your perspective. We wish you the best in your future endeavors.
See reviews by: Helpful|Rating|Date|All